Liraglutide Research peptides

Product name:Liraglutide

CAS# 204656-20-2

Specification: 10MG

Purity: 99%

Appearance: White Lyophilized Powder

Solubility: Water-soluble

Liraglutide is a high-purity long-acting synthetic GLP-1 analog peptide, manufactured through standardized solid-phase peptide synthesis and sophisticated modification purification technology. Structurally optimized based on human native GLP-1 sequence with palmitic acid fatty chain modification, it features stronger molecular stability and prolonged half-life compared with ordinary GLP-1 fragments. The product appears as white lyophilized powder, with high purity, low impurity content and excellent batch consistency, widely used for laboratory basic research, GLP-1 receptor mechanism study, cell-level pharmacological exploration and related preclinical scientific research projects.

Main Application Scenarios

This research-grade peptide is only applicable to laboratory basic scientific research. Core research directions include GLP-1 receptor activation mechanism study, cell signal pathway exploration, metabolic mechanism basic research, peptide structural modification & structure-activity relationship analysis, long-acting polypeptide drug prototype research and preclinical pharmacological experiments. Suitable for university laboratories, medical research institutes, pharmaceutical R&D institutions and biotechnology research teams for basic academic research and experimental analysis.

Strictly for Laboratory Research Use Only. Not for human consumption, clinical medication, medical diagnosis, treatment application, cosmetic addition, food processing or any civilian and commercial use. This product is a pure research chemical raw material, not a finished drug, health product or medical device. All descriptions are limited to chemical properties, structural characteristics and laboratory research applications, with no medical efficacy or therapeutic implication.